Emmaus Life Sciences, Inc. financial data

Symbol
EMMA on OTC
Industry
Pharmaceutical Preparations
Location
21250 Hawthorne Boulevard, Suite 800, Torrance, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
MYnd Analytics, Inc. (to 7/12/2019), CNS RESPONSE, INC. (to 12/10/2015), STRATIVATION, INC. (to 3/1/2007), SalesTactix, Inc. (to 8/23/2005), AGE RESEARCH INC (to 8/5/2004)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 14.9 % +6.58%
Quick Ratio 2.57 % -25.3%
Debt-to-equity -156 % +33.9%
Return On Assets -11.9 % -21.8%
Operating Margin 0.09 % -96.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.9M shares
Common Stock, Shares, Outstanding 63.9M shares +19.1%
Entity Public Float 8.86M USD -43.2%
Common Stock, Value, Issued 64K USD +18.5%
Weighted Average Number of Shares Outstanding, Basic 63.9M shares +19.1%
Weighted Average Number of Shares Outstanding, Diluted 163M shares +17.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 20.4M USD -28.2%
Cost of Revenue 1.08M USD -39.7%
Research and Development Expense 686K USD -55.8%
Selling and Marketing Expense 7.18M USD -18.1%
General and Administrative Expense 11.5M USD -26.4%
Operating Income (Loss) 18K USD -97.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.59M USD +23.3%
Income Tax Expense (Benefit) -89K USD -229%
Net Income (Loss) Attributable to Parent -3.5M USD +26.3%
Earnings Per Share, Basic -0.04 USD/shares +55.6%
Earnings Per Share, Diluted -0.07 USD/shares +30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.26M USD -16.6%
Accounts Receivable, after Allowance for Credit Loss, Current 4.94M USD +7.65%
Inventory, Net 1.61M USD -2.42%
Other Assets, Current 817K USD +26.3%
Assets, Current 9.2M USD -0.57%
Property, Plant and Equipment, Net 49K USD -18.3%
Operating Lease, Right-of-Use Asset 1.72M USD -31.5%
Other Assets, Noncurrent 312K USD +6.49%
Assets 27.3M USD -42.4%
Accounts Payable, Current 6.49M USD +35%
Employee-related Liabilities, Current 1.26M USD +15.1%
Accrued Liabilities, Current 7.86M USD -3.68%
Liabilities, Current 64.1M USD +5.28%
Operating Lease, Liability, Noncurrent 1.08M USD -48%
Other Liabilities, Noncurrent 13.7M USD -20.7%
Liabilities 81.1M USD -3.17%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.02M USD -34.1%
Retained Earnings (Accumulated Deficit) -261M USD -1.36%
Stockholders' Equity Attributable to Parent -53.8M USD -48%
Liabilities and Equity 27.3M USD -42.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 140K USD
Net Cash Provided by (Used in) Financing Activities -955K USD -145%
Net Cash Provided by (Used in) Investing Activities -4K USD +99.6%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 63.9M shares +19.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -835K USD -238%
Interest Paid, Excluding Capitalized Interest, Operating Activities 873K USD +216%
Deferred Tax Assets, Valuation Allowance 42.9M USD -2.76%
Deferred Tax Assets, Gross 43.3M USD -2.73%
Operating Lease, Liability 3.41M USD +17.4%
Depreciation 24K USD -29.4%
Payments to Acquire Property, Plant, and Equipment 4K USD -33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.01M USD -1079%
Lessee, Operating Lease, Liability, to be Paid 3.65M USD +5.83%
Property, Plant and Equipment, Gross 525K USD +1.94%
Operating Lease, Liability, Current 2.33M USD +180%
Lessee, Operating Lease, Liability, to be Paid, Year Two 846K USD -27.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.13M USD -0.53%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 243K USD -55.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 856K USD -21.6%
Deferred Tax Assets, Operating Loss Carryforwards 17.6M USD -2.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 836K USD
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -124K USD -103%
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 6K USD -33.3%
Deferred Tax Assets, Net of Valuation Allowance 427K USD 0%
Interest Expense 6.39M USD -4.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%